EP2167480 - CATIONIC LIPIDS COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSES TO VACCINES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 06.01.2017 Database last updated on 09.09.2024 | Most recent event Tooltip | 06.01.2017 | Application deemed to be withdrawn | published on 08.02.2017 [2017/06] | Applicant(s) | For all designated states VICAL INCORPORATED 10390 Pacific Center Court San Diego, California 92121-4340 / US | [2010/13] | Inventor(s) | 01 /
HARTIKKA, Jukka 3920 Brooke Court La Mesa, California 91941-7894 / US | 02 /
SULLIVAN, Sean, M. 7638 Heatherly Lane San Diego, California 92130 / US | 03 /
ENAS, Joel, D. 210 Sky Country Court Fallbrook, California 92028 / US | 04 /
ROLLAND, Alain 10696 Edenoaks Street San Diego, California 92131 / US | [2010/13] | Representative(s) | Roques, Sarah Elizabeth J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | [N/P] |
Former [2010/13] | Roques, Sarah Elizabeth J.A. Kemp & Co. 14 South Square Gray's Inn GB-London WC1R 5JJ / GB | Application number, filing date | 08769711.6 | 23.05.2008 | [2010/13] | WO2008US64786 | Priority number, date | US20070939702P | 23.05.2007 Original published format: US 939702 P | US20080044338P | 11.04.2008 Original published format: US 44338 P | [2016/11] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2008148057 | Date: | 04.12.2008 | Language: | EN | [2008/49] | Type: | A2 Application without search report | No.: | EP2167480 | Date: | 31.03.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.12.2008 takes the place of the publication of the European patent application. | [2010/13] | Search report(s) | International search report - published on: | EP | 19.02.2009 | Classification | IPC: | C07D295/13, C07C217/28, A61K39/39, A61K47/18, A61P31/04, A61P31/12, A61P35/00, C07D211/46 | [2010/13] | CPC: |
C07C217/28 (EP,US);
C12N15/88 (US);
A61K39/39 (US);
A61P31/04 (EP);
A61P31/12 (EP);
A61P35/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/13] | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERBESSERUNG DER IMMUNREAKTIONEN AUF IMPFSTOFFE | [2010/13] | English: | CATIONIC LIPIDS COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSES TO VACCINES | [2010/13] | French: | COMPOSITIONS ET PROCÉDÉS POUR AMÉLIORER LA RÉPONSE IMMUNITAIRE À DES VACCINS | [2010/13] | Entry into regional phase | 22.12.2009 | National basic fee paid | 22.12.2009 | Designation fee(s) paid | 22.12.2009 | Examination fee paid | Examination procedure | 22.12.2009 | Examination requested [2010/13] | 02.03.2010 | Amendment by applicant (claims and/or description) | 30.06.2010 | Despatch of a communication from the examining division (Time limit: M06) | 06.01.2011 | Reply to a communication from the examining division | 01.03.2011 | Despatch of a communication from the examining division (Time limit: M06) | 09.09.2011 | Reply to a communication from the examining division | 12.01.2012 | Despatch of a communication from the examining division (Time limit: M06) | 19.07.2012 | Reply to a communication from the examining division | 30.07.2012 | Despatch of a communication from the examining division (Time limit: M06) | 06.02.2013 | Reply to a communication from the examining division | 26.02.2013 | Despatch of a communication from the examining division (Time limit: M06) | 23.07.2013 | Reply to a communication from the examining division | 19.09.2013 | Despatch of a communication from the examining division (Time limit: M06) | 27.02.2014 | Reply to a communication from the examining division | 18.09.2014 | Despatch of a communication from the examining division (Time limit: M04) | 22.01.2015 | Reply to a communication from the examining division | 20.05.2015 | Despatch of a communication from the examining division (Time limit: M04) | 17.09.2015 | Reply to a communication from the examining division | 31.03.2016 | Communication of intention to grant the patent | 11.08.2016 | Application deemed to be withdrawn, date of legal effect [2017/06] | 16.09.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2017/06] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 30.06.2010 | Fees paid | Renewal fee | 31.03.2010 | Renewal fee patent year 03 | 10.05.2011 | Renewal fee patent year 04 | 21.03.2012 | Renewal fee patent year 05 | 26.03.2013 | Renewal fee patent year 06 | 26.03.2014 | Renewal fee patent year 07 | 07.05.2015 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 31.05.2016 | 09   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO9405624 (LIFE TECHNOLOGIES INC [US]) [X] 1 * claims 1,3,4,... *; | [X]WO9814439 (VICAL INC [US], et al) [X] 42-67,69-84 * figures 1-7; claims 1-37 *; | [X]US6670332 (WHEELER CARL J [US]) [X] 1-8,15-24,28-37 * the whole document * * claims 51,52 * * example 12 *; | [X]WO2004105697 (MOLECULAR TRANSFER INC [US], et al) [X] 1 * compound 13 *; | [XD]US7105574 (WHEELER CARL J [US]) [XD] 1-7,15-26,28-41,83-85 * columns 3,4,6; figures 2-4 *; | [X] - FERRARI MARILYN E ET AL, "Synergy between cationic lipid and co-lipid determines the macroscopic structure and transfection activity of lipoplexes.", NUCLEIC ACIDS RESEARCH 15 APR 2002, (20020415), vol. 30, no. 8, ISSN 1362-4962, pages 1808 - 1816, XP002497337 [X] 1-7,15-26 * the whole document * DOI: http://dx.doi.org/10.1093/nar/30.8.1808 | [X] - WHEELER C J ET AL, "CONVERTING AN ALCOHOL TO AN AMINE IN A CATIONIC LIPID DRAMATICALLY ALTERS TO CO-LIPID REQUIREMENT, CELLULAR TRANSFECTION ACTIVITY AND THE ULTRASTRUCTURE OF DNA-CYTOFECTIN COMPLEXES", BIOCHIMICA ET BIOPHYSICA ACTA, AMSTERDAM, (19960101), vol. 1280, no. 1, ISSN 0006-3002, pages 1 - 11, XP002035803 [X] 1,2 * the whole document * DOI: http://dx.doi.org/10.1016/0005-2736(95)00256-1 | [XD] - WHEELER C J ET AL, "A NOVEL CATIONIC LIPID GREATLY ENHANCES PLASMID DNA DELIVERY AND EXPRESSION IN MOUSE LUNG", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC.; US, (19961001), vol. 93, ISSN 0027-8424, pages 11454 - 11459, XP000946063 [XD] 1,2 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.93.21.11454 | [X] - MENGER F M ET AL, "Lipid-catalyzed transport of copper(II) through liquid membranes", JOURNAL OF ORGANIC CHEMISTRY, (1993), vol. 58, no. 7, ISSN 0022-3263, pages 1909 - 1916, XP002497607 [X] 1 * compound 2 * DOI: http://dx.doi.org/10.1021/jo00059a050 | [X] - MANTHORPE M ET AL, "Plasmid vaccines and therapeutics: from design to applications", ADVANCES IN BIOCHEMICAL ENGINEERING, BIOTECHNOLOGY, SPRINGER, BERLIN, DE, (20050101), vol. 99, ISSN 0724-6145, pages 41 - 92, XP008097068 [X] 83-85 * page 44 * * page 68 - page 72; table 6 * DOI: http://dx.doi.org/10.1007/10_003 | [A] - NICULESCU-DUVAZ DAN ET AL, "Structure-activity relationship in cationic lipid mediated gene transfection.", CURRENT MEDICINAL CHEMISTRY JUL 2003, (200307), vol. 10, no. 14, ISSN 0929-8673, pages 1233 - 1261, XP008099342 [A] * the whole document * DOI: http://dx.doi.org/10.2174/0929867033457476 | [A] - KARMALI PRIYA PRAKASH ET AL, "Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises.", MEDICINAL RESEARCH REVIEWS SEP 2007, (20061004), vol. 27, no. 5, ISSN 0198-6325, pages 696 - 722, XP002506974 DOI: http://dx.doi.org/10.1002/MED.20090 | [A] - MAJETI BHARAT KUMAR ET AL, "Enhanced intravenous transgene expression in mouse lung using cyclic-head cationic lipids.", CHEMISTRY & BIOLOGY APR 2004, (200404), vol. 11, no. 4, ISSN 1074-5521, pages 427 - 437, XP002506975 DOI: http://dx.doi.org/10.1016/J.CHEMBIOL.2004.03.015 | by applicant | US7105574 | - FELGNER, SCIENTIFIC AMERICAN, (1997), vol. 276, no. 6, pages 102 - 106 | - BINS; A. D.; A. JORRITSMA ET AL., "A ranid and notent DNA vaccination strategy defined by in vivo monitoring of antigen expression", NAT MED, (2005), vol. 11, no. 8, pages 899 - 904 | - HARTIKKA, J.; V. BOZOUKOVA ET AL., "Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens", VACCINE, (2001), vol. 19, no. 15-16, pages 1911 - 23 |